1. Home
  2. CRAI vs HRMY Comparison

CRAI vs HRMY Comparison

Compare CRAI & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRAI
  • HRMY
  • Stock Information
  • Founded
  • CRAI 1965
  • HRMY 2017
  • Country
  • CRAI United States
  • HRMY United States
  • Employees
  • CRAI N/A
  • HRMY N/A
  • Industry
  • CRAI Other Consumer Services
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRAI Consumer Discretionary
  • HRMY Health Care
  • Exchange
  • CRAI Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • CRAI 1.4B
  • HRMY 1.5B
  • IPO Year
  • CRAI 1998
  • HRMY 2020
  • Fundamental
  • Price
  • CRAI $180.57
  • HRMY $31.40
  • Analyst Decision
  • CRAI Buy
  • HRMY Strong Buy
  • Analyst Count
  • CRAI 1
  • HRMY 9
  • Target Price
  • CRAI $239.00
  • HRMY $50.44
  • AVG Volume (30 Days)
  • CRAI 76.3K
  • HRMY 912.0K
  • Earning Date
  • CRAI 10-30-2025
  • HRMY 11-04-2025
  • Dividend Yield
  • CRAI 1.09%
  • HRMY N/A
  • EPS Growth
  • CRAI 34.79
  • HRMY 50.44
  • EPS
  • CRAI 8.34
  • HRMY 3.17
  • Revenue
  • CRAI $731,055,000.00
  • HRMY $825,944,000.00
  • Revenue This Year
  • CRAI $10.26
  • HRMY $20.68
  • Revenue Next Year
  • CRAI $3.48
  • HRMY $15.93
  • P/E Ratio
  • CRAI $21.64
  • HRMY $9.92
  • Revenue Growth
  • CRAI 8.69
  • HRMY 21.13
  • 52 Week Low
  • CRAI $152.57
  • HRMY $25.52
  • 52 Week High
  • CRAI $214.66
  • HRMY $40.93
  • Technical
  • Relative Strength Index (RSI)
  • CRAI 41.62
  • HRMY 63.59
  • Support Level
  • CRAI $176.14
  • HRMY $27.66
  • Resistance Level
  • CRAI $194.39
  • HRMY $30.96
  • Average True Range (ATR)
  • CRAI 6.08
  • HRMY 1.25
  • MACD
  • CRAI 0.39
  • HRMY 0.54
  • Stochastic Oscillator
  • CRAI 23.06
  • HRMY 92.89

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: